| Model Number |
23VAVGJ-515 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Hemorrhage/Blood Loss/Bleeding (1888); Unspecified Infection (1930)
|
| Date of Event |
01/09/2023
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
Clinical study patient id: (b)(6) ((b)(6),(b)(6)).It was reported that on (b)(6) 2023, a 23mm sjm masters series valsalva aortic valved graft was implanted into a patient.The patient had a high amount of blood drainage post operatively for 30 minutes.Surgical intervention was performed and 3 units of blood and blood products given.On (b)(6) 2023, the patient have elevated c-reactive protein and leukocytosis.An unspecified infection is suspected and medication was administered.No patient consequences were reported.No additional information was provided.
|
| |
|
Additional Manufacturer Narrative
|
|
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
| |
|
Additional Manufacturer Narrative
|
|
An event of bleeding, elevated c-reactive protein, leukocytosis and unspecified infection was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
|
| |
|
Search Alerts/Recalls
|